Hostname: page-component-76fb5796d-9pm4c Total loading time: 0 Render date: 2024-04-26T15:02:11.948Z Has data issue: false hasContentIssue false

Medicines management audit cycle, St. Brigid’s Hospital Ballinasloe

Published online by Cambridge University Press:  02 October 2014

R. Murphy*
Affiliation:
Department of Psychiatry, National University of Ireland Galway, Galway, Ireland
G. Grehan
Affiliation:
Health Service Executive, East Galway Mental Health Services, Ballinalsoe, Co. Galway, Ireland
V. Hays
Affiliation:
Health Service Executive, East Galway Mental Health Services, Ballinalsoe, Co. Galway, Ireland
G. Freeman
Affiliation:
Health Service Executive, East Galway Mental Health Services, Ballinalsoe, Co. Galway, Ireland
P. Kerr
Affiliation:
Health Service Executive, East Galway Mental Health Services, Ballinalsoe, Co. Galway, Ireland
S. Fahy
Affiliation:
Health Service Executive, East Galway Mental Health Services, Ballinalsoe, Co. Galway, Ireland
*
*Address for correspondence: R. Murphy, Department of Psychiatry, National University of Ireland Galway, Galway, Ireland. (Email: ruthannmurphy1@gmail.com)

Abstract

Objectives

This audit cycle aimed to identify deficiencies in medicines management in an adult psychiatric hospital. The original audit in 2009 highlighted that a number of improvements were needed to enhance prescribing standards. Following implementation of these recommendations, two reaudits were performed to assess both the improvements in medicines management along with evaluating the newly introduced drug prescription chart.

Methods

Local, national and international guidelines on medicines management were reviewed in 2009, following which an audit tool was designed. Recommendations from the original audit were taken on board with the introduction of a new medication chart. This chart incorporated many of the recommendations from the original audit into it. Two reaudits were then performed, each over 1 day by four assessors and included all inpatient wards.

Results

The initial audit in 2009 outlined a number of recommendations, namely the introduction of an appropriate ‘fit for purpose’ medication chart, the need for regular postgraduate prescribing education and training and the consideration of a prescribing formulary and/or Drugs & Therapeutics Committee. Results from the reaudits revealed that considerable improvement was made in areas such as patient demographics, pharmacist involvement, generic prescribing, BLOCK capitals, inclusion of Medical Council Registration Number, PRN prescribing and discontinuation procedures.

Conclusion

Although significant improvement was noted, further improvement is required with regards to the need for a review date for PRN medication; the need for improved documentation of allergies, height and weight; and the importance of a working group to assess community medicines management and the need for further reaudits to assess continued improvement in all deficient areas.

Type
Audit Paper
Copyright
© College of Psychiatrists of Ireland 2014 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Ammenwerth, E, Schnell-Inderst, P, Machan, C (2008). The effect of electronic prescribing on medication errors and adverse drug events: a systematic review. Journal of the American Medical Informatics Association 15, 585600.CrossRefGoogle ScholarPubMed
An Bord Altranais (2007). Guidance to Nurses & Midwives on Medication Management. The Nursing and Midwifery Board of Ireland, An Bord Altranias: Dublin, Ireland.Google Scholar
Audit Commission (1994). A Prescription Towards More Rational Prescribing in General Practice. The Audit Commission for Local Authorities and the National Health Service in England and Wales: London, England.Google Scholar
Barber, N, Rawlins, M, Franklin, B (2003). Reducing prescribing error: competence, control and culture. Quality and Safety in Health Care 12, 129132.CrossRefGoogle ScholarPubMed
Bell, DS, Cretin, S, Marken, RS, Landman, AB (2004). A conceptual framework for evaluating outpatient prescribing systems based on their functional capabilities. Journal of the American Medical Informatics Association 11, 6070.CrossRefGoogle ScholarPubMed
Dean, B (2002). Causes of prescribing errors in hospital inpatients: a prospective study. The Lancet 359, 13731378.CrossRefGoogle ScholarPubMed
Department of Health (2000). Pharmacy in the Future: Implementing the NHS Plan. National Health Service (NHS): London, England.Google Scholar
Department of Health (2001). Spoonful of Sugar: Medicines Management in NHS Hospitals. National Health Service (NHS): London, England.Google Scholar
Department of Health & Children (2008). Building a Culture of Patient Safety. Department of Health and Children, Government Publications Sale Office: Dublin, Ireland.Google Scholar
Dequito, AB, Mol, PG, van Doormaal, JE, Zaal, RJ, van dem Bemt, PM, Haaijer-Ruskamp, FM, Kosterink, JG (2011). Preventable and non-preventable adverse drug events in hospitalized patients: a perspective chart review in the Netherlands. Drug Safety 34, 10891100.CrossRefGoogle Scholar
DTP (2000). 15, 11–13.CrossRefGoogle Scholar
East Galway Mental Health Service (2007). Policy on Medication Management and Drug Prescribing Guidelines. East Galway Mental Health Service Audit Committee: Ballinasloe, Co. Galway, Ireland.Google Scholar
Health Information and Quality Authority (HIQA) (2008). National Quality Standards for Residential Care Setting. HIQA. pp. 20–22 (www.hiqa.ie/systems).Google Scholar
Irish Medical Council (2009). Guide to Professional Conduct and Ethics for Registered Medical Practitioners, 7th edn. Irish Medical Council: Dublin, Ireland (www.medicalcouncil.ie). Accessed July 2009.Google Scholar
Keogh, B (2011). Standards for the design of hospital in-patient prescription charts. Report prepared for Sir Bruce Keogh, Academy of Medical Royal Colleges in Collaboration with the Royal Pharmaceutical Society and Royal College of Nursing: London, England (www.bps.ac.uk). Accessed January 2009.Google Scholar
Kirke, C (2009). Medication safety in hospitals. Irish Medical Journal 102, 339341.Google ScholarPubMed
Kohn, L, Corrigan, J, Donaldson, M (1999). Committee on Quality of Health Care in America, Institute of Medicine. To Err is Human: Building a Safer Health System. National Academy Press: Washington, DC.Google Scholar
MDU (1996). MDU Risk Management. Medical Defense Union: London, England, pp. 1–8.Google Scholar
Mental Health Commission (2008). Mental Health Commission Annual Report, Book 1, Appendix 6: Medication Prescriptions in Approved Centres. Mental Health Commission: Dublin, Ireland, pp. 85–88.Google Scholar
Miller, AJ, Silla, RC, Lee, GE, Berwick, A (2008). The National Inpatient Medication Chart: critical audit of design and performance at a tertiary hospital. Medical Journal of Australia 188, 9599.CrossRefGoogle Scholar
MPS (1999). MPS Casebook. Medical Protection Society: London, England, pp. 9–10.Google Scholar
National Medicines Information Centre (2001). St. James Hospital, Dublin. Bulletin on Medication Errors 7, 14, (www.nmic.ie).Google Scholar
The Pharmaceutical Society of Ireland (2008). Pharmacy Practice Guidance Manual. The Pharmaceutical Society of Ireland: Dublin Ireland. pp. 50–52 (www.thepsi.ie). Accessed July 2009.Google Scholar
Pirmohamed, M, James, S, Meakin, S, Green, C, Scott, AK, Walley, TJ, Farrar, K, Park, BK, Breckenridge, AM (2004). Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients. British Medical Journal 329, 1519.CrossRefGoogle Scholar
Reason, J (2000). Human error. Models and management. British Medical Journal 320, 768770.CrossRefGoogle ScholarPubMed
Rybackii, JJ (1997). Adverse drug events in hospitalized patients. Journal of the American Medical Association 277, 307311.Google Scholar
Schnipper, JL (2011). Medication safety: are we there yet? Comment on ‘potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients’. Archives of Internal Medicine 171, 10191020.CrossRefGoogle ScholarPubMed
Scullin, C, Scott, M, Hogg, A, McElnay, JC (2007). An innovative approach to integrated medicines management. Journal of Evaluation in Clinical Practice 13, 781788.CrossRefGoogle ScholarPubMed
Simpson, D (2001). What is medicines management and what is pharmaceutical care? Pharmaceutical Journal 266, 150.Google Scholar
Smith, J (2004). Building a Safer NHS for Patients: Improving Medication Safety. Department of Health: London, UK. (www.dh.gov.uk/publications). Accessed July 2009.Google Scholar
Stowasser, D, Allinson, Y, O’Leary, K (2004). Understanding the medicines management pathway. Journal of Pharmacy Practice and Research 34, 293296.CrossRefGoogle Scholar
Weingart, SN, Wilson, RM, Gibberd, RW, Harrison, B (2000). Epidemiology of medical error. British Medical Journal 320, 774777.CrossRefGoogle ScholarPubMed